Search results
Showing 361 to 368 of 368 search results for We publish complaints data every.
-
Financial services regulation and enforcement: recent developments and emerging issues
Speech by Tracey McDermott, Director of Enforcement and Financial Crime at the NERA Economic Consulting seminar, London. This is the text of the speech as drafted, which may differ from the delivered version. -
Firms’ preparations to comply with the cryptoasset financial promotions regime – feedback on good and poor practice
The FCA met with various regulated cryptoasset firms to understand how prepared they were. See findings and examples of good and poor practice. -
Authorised fund managers’ assessments of their funds’ value
This review sets out our findings from our review, where we looked at the processes used by different Authorised Fund Managers (AFMs) when they carry out assessments of value (AoVs or 'Value Assessments') for the funds they operate. -
Review of terminal illness benefits within life insurance protection products
FCA review of insurance companies’ approaches to terminal illness benefits to make recommendations for improvement. -
Coronavirus linked forbearance: key findings
We set out our findings from our review, where we considered mortgage and consumer credit firms' implementation of Tailored Support Guidance since November 2020 and the operational readiness of firms to support customers in financial difficulty. -
Principal firms who have Credit Broking permissions: Good practice and areas for improvements
We assessed the key harms and drivers of harm caused by ARs and IARs who undertake credit broking. We found some examples of good and poor practice that we'd like to share with firms, as we think they can improve their practices. -
Trust and confidence - ensuring firms’ ethics are built around their customers
Speech by Clive Adamson, Director of Supervision, at the Insurance Institute of London, London. This is the text of the speech as drafted, which may differ from the delivered version. -
General insurance product value and coronavirus (Covid-19) Guidance – update
We set out the findings from our multi-firm review assessing how firms have responded to our general insurance (GI) distribution chain Guidance (further to the product governance rules implemented by the IDD) and coronavirus (Covid-19) value Guidance